BNTC
Benitec Biopharma Ltd
11.00$
-3.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| 3.7% | 30.0% | 81.7% | 10.8% | 3.6% | -190.7% | 208.5% | 12.3% | 508.0% | 158.8% | – | – | |
| 96.3% | 70.0% | 18.3% | 89.7% | 91.1% | 290.7% | -108.5% | 87.7% | 100.0% | -158.8% | – | – | |
| 576.1% | 2,863.6% | 2,079.6% | 84.7% | 18.3% | 3,093.8% | 11,898.3% | 15,441.1% | 17,032.0% | 7,226.4% | – | – | |
| 744.2% | 2,523.9% | 2,731.5% | 107.2% | 18.5% | 5,739.2% | 11,037.3% | 9,104.1% | 8,509.3% | 3,235.6% | – | – | |
| 1,703.9% | 7,274.3% | 6,241.2% | 377.8% | 75.3% | 8,827.8% | 22,935.6% | 24,545.2% | 25,541.3% | 10,412.0% | – | – | |
| -1,607.6% | -7,204.2% | -8,132.4% | -198.4% | 21.2% | -8,537.1% | -23,044.1% | -24,457.5% | -25,441.3% | -10,412.0% | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 63.9% | 10.2% | 43.8% | 44.0% | 418.5% | – | – | |
| -1,064.7% | -5,340.1% | -1,708.7% | -194.3% | 21.4% | -8,529.9% | -23,528.8% | -24,942.5% | -26,082.7% | -10,069.9% | – | – | |
| 130.3% | -3,482.1% | -5,282.0% | -95.6% | -5.3% | 27.8% | -171.2% | 484.9% | 4.0% | -286.6% | – | – | |
| -1,064.7% | -5,340.1% | -2,860.4% | -280.1% | 21.4% | -8,529.9% | -23,528.8% | -24,942.5% | -26,082.7% | -10,069.9% | – | – | |
| -956.6% | -8,142.2% | -1,637.5% | -143.6% | 11.0% | -8,151.5% | -22,800.0% | -24,361.6% | -24,933.3% | -10,253.2% | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.